108 related articles for article (PubMed ID: 15465925)
1. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.
Liu C; Chen J; Kuei C; Sutton S; Nepomuceno D; Bonaventure P; Lovenberg TW
Mol Pharmacol; 2005 Jan; 67(1):231-40. PubMed ID: 15465925
[TBL] [Abstract][Full Text] [Related]
2. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays.
Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD
Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442
[TBL] [Abstract][Full Text] [Related]
3. A novel G protein-coupled receptor for starfish gonadotropic hormone, relaxin-like gonad-stimulating peptide.
Mita M; Matsubara S; Osugi T; Shiraishi A; Wada A; Satake H
PLoS One; 2020; 15(11):e0242877. PubMed ID: 33226996
[TBL] [Abstract][Full Text] [Related]
4. Review: The evolution of peptidergic signaling in Cnidaria and Placozoa, including a comparison with Bilateria.
Hauser F; Koch TL; Grimmelikhuijzen CJP
Front Endocrinol (Lausanne); 2022; 13():973862. PubMed ID: 36213267
[TBL] [Abstract][Full Text] [Related]
5. Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.
Hombach-Klonisch S; Bialek J; Trojanowicz B; Weber E; Holzhausen HJ; Silvertown JD; Summerlee AJ; Dralle H; Hoang-Vu C; Klonisch T
Am J Pathol; 2006 Aug; 169(2):617-32. PubMed ID: 16877360
[TBL] [Abstract][Full Text] [Related]
6. Relaxin family peptide systems and the central nervous system.
Callander GE; Bathgate RA
Cell Mol Life Sci; 2010 Jul; 67(14):2327-41. PubMed ID: 20213277
[TBL] [Abstract][Full Text] [Related]
7. Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1.
Xiao J; Huang Z; Chen CZ; Agoulnik IU; Southall N; Hu X; Jones RE; Ferrer M; Zheng W; Agoulnik AI; Marugan JJ
Nat Commun; 2013; 4():1953. PubMed ID: 23764525
[TBL] [Abstract][Full Text] [Related]
8. Developing insulin-like peptide 5-based antagonists for the G protein-coupled receptor, RXFP4.
Wu H; Handley TNG; Hoare BL; Hartono HA; Scott DJ; Chalmers DK; Bathgate RAD; Hossain MA
Biochem Pharmacol; 2024 Jun; 224():116239. PubMed ID: 38679208
[TBL] [Abstract][Full Text] [Related]
9. Relaxin-like peptides in male reproduction - a human perspective.
Ivell R; Agoulnik AI; Anand-Ivell R
Br J Pharmacol; 2017 May; 174(10):990-1001. PubMed ID: 27933606
[TBL] [Abstract][Full Text] [Related]
10. Mode matches and their locations in the hydrophobic free energy sequences of peptide ligands and their receptor eigenfunctions.
Mandell AJ; Selz KA; Shlesinger MF
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13576-81. PubMed ID: 9391068
[TBL] [Abstract][Full Text] [Related]
11. Arthropod IGF, relaxin and gonadulin, putative orthologs of
Veenstra JA
PeerJ; 2020; 8():e9534. PubMed ID: 32728497
[TBL] [Abstract][Full Text] [Related]
12. Is the Neuropeptide PEN a Ligand of GPR83?
Giesecke Y; Asimi V; Stulberg V; Kleinau G; Scheerer P; Koksch B; Grötzinger C
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894796
[TBL] [Abstract][Full Text] [Related]
13. Characterization of relaxin 3 and its receptors in chicken: Evidence for relaxin 3 acting as a novel pituitary hormone.
Lv C; Zheng H; Jiang B; Ren Q; Zhang J; Zhang X; Li J; Wang Y
Front Physiol; 2022; 13():1010851. PubMed ID: 36419837
[TBL] [Abstract][Full Text] [Related]
14. Relaxin ligand/receptor systems in the developing teleost fish brain: Conserved features with mammals and a platform to address neuropeptide system functions.
Blasiak A; Gugula A; Gundlach AL; Olucha-Bordonau FE; Aniello F; Donizetti A
Front Mol Neurosci; 2022; 15():984524. PubMed ID: 36277494
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Characterization of the First Nonpeptide Antagonists for the Relaxin-3/RXFP3 System.
Gay EA; Guan D; Van Voorhies K; Vasukuttan V; Mathews KM; Besheer J; Jin C
J Med Chem; 2022 Jun; 65(11):7959-7974. PubMed ID: 35594150
[TBL] [Abstract][Full Text] [Related]
16. The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease.
Leysen H; Walter D; Clauwaert L; Hellemans L; van Gastel J; Vasudevan L; Martin B; Maudsley S
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457203
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput Screening Campaign Identified a Potential Small Molecule RXFP3/4 Agonist.
Lin G; Feng Y; Cai X; Zhou C; Shao L; Chen Y; Chen L; Liu Q; Zhou Q; Bathgate RAD; Yang D; Wang MW
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946593
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the
Gil-Miravet I; Mañas-Ojeda A; Ros-Bernal F; Castillo-Gómez E; Albert-Gascó H; Gundlach AL; Olucha-Bordonau FE
Front Neuroanat; 2021; 15():637922. PubMed ID: 33867946
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Use of Helicogenic Amino Acids for Optimising Single Chain Relaxin-3 Peptide Agonists.
Lee HS; Wang SH; Daniel JT; Hossain MA; Clark RJ; Bathgate RAD; Rosengren KJ
Biomedicines; 2020 Oct; 8(10):. PubMed ID: 33066369
[TBL] [Abstract][Full Text] [Related]
20. Development of Relaxin-3 Agonists and Antagonists Based on Grafted Disulfide-Stabilized Scaffolds.
Lee HS; Postan M; Song A; Clark RJ; Bathgate RAD; Haugaard-Kedström LM; Rosengren KJ
Front Chem; 2020; 8():87. PubMed ID: 32133341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
